AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

Dexmedetomidine

9 registrations across 4 African markets— 5 active

Markets with Dexmedetomidine

Recent registrations

Brand / ProductMarketHolderStatusExpires
PRECIDEX INJECTION
Injection
🇷🇼RwandaBROOKES PHARMA (PRIVATE) LIMITEDactiveMay 2030
DEXMEDETOMIDINE EVER PHARMA
Solution injectable pour perfusion / 1000µg/10ml (100µg/ml)
🇹🇳TunisiaEVER Valinject GmbHexpiredJan 2024
DEXMEDETOMIDINE EVER PHARMA
Solution injectable pour perfusion / 400µg/4ml (100µg/ml)
🇹🇳TunisiaEVER Valinject GmbHexpiredJan 2024
DEXMEDETOMIDINE EVER PHARMA
Solution injectable pour perfusion / 200µg/2ml (100µg/ml)
🇹🇳TunisiaEVER Valinject GmbHexpiredJan 2024
PROXIDA
Solution injectable pour perfusion / 200 µG/2ml
🇹🇳TunisiaHIKMA PharmaceuticalsexpiredJan 2024
DEXDOMITOR🇿🇦South AfricaZoetis South Africa (Pty) LtdactiveJan 1900
PreceDEX🇿🇦South AfricaPfizer Laboratories (Pty) LtdactiveJan 1900
Precidex Injection
Injection
🇹🇿TanzaniaBROOKES PHARMA PVT LIMITEDactive
dexem
Solution for injection
🇹🇿TanzaniaThemis Medicareactive

Dexmedetomidine in Africa — Regulatory Overview

Dexmedetomidine is registered across 4 African markets with 9 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Tunisia, Tanzania, South Africa, Rwanda. AfricaRegulatory refreshes this data daily from official government sources.

Of the 9 registrations, 5 (56%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.